Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1991-8-9
|
pubmed:abstractText |
We have recently shown that priming mice with allogeneic strain A spleen cells before immunization with (A x B)F1 spleen cells strongly suppresses the cytotoxic T-lymphocyte (CTL) response directed against linked strain B alloantigens. This specific decrease in the CTL responses against the second immunizing alloantigen is associated with a high CTL response against the first priming alloantigen. The suppression of CTL responses against the strain B alloantigens is, however, not due to killing of F1 spleen cells by anti-A CTL, since it was observed after immunization of primed mice with a mixture of (A x B)F1 and B cells. In the present study, attempts were made to determine the relative contribution of H-2 and minor histocompatibility background antigens towards induction of suppression. Our results demonstrate that priming and immunizing spleen cells have only to share H-2 antigens in order to induce a downregulation of CTL responses directed against the linked alloantigens. This indicates that immunity against H-2 antigens is sufficient to induce suppression. However, priming against minor histocompatibility antigens also induces suppression, but only if spleen cells used for priming and immunization share H-2 antigens with the recipient strain. Therefore, the suppression can be induced by priming with non-H-2 antigens but is H-2-restricted. This study has also demonstrated that suppression can be induced by intraperitoneal or subcutaneous administration of allogeneic cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0923-2494
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
141
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
839-53
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1712502-Animals,
pubmed-meshheading:1712502-Cytotoxicity, Immunologic,
pubmed-meshheading:1712502-Drug Administration Routes,
pubmed-meshheading:1712502-Epitopes,
pubmed-meshheading:1712502-H-2 Antigens,
pubmed-meshheading:1712502-Immune Tolerance,
pubmed-meshheading:1712502-Isoantigens,
pubmed-meshheading:1712502-Major Histocompatibility Complex,
pubmed-meshheading:1712502-Mice,
pubmed-meshheading:1712502-Mice, Inbred Strains,
pubmed-meshheading:1712502-Minor Histocompatibility Antigens,
pubmed-meshheading:1712502-Spleen,
pubmed-meshheading:1712502-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:1712502-Tumor Cells, Cultured
|
pubmed:articleTitle |
Role of major and minor histocompatibility antigens in the suppression of alloreactive cytotoxic responses induced by alloantigen pretreatment.
|
pubmed:affiliation |
Laboratoire de Biologie des Régulations Immunitaires, Institut Pasteur, Paris.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|